Today Opportunities Markets Hot News AI Chat

EN

Tickwind

Read every tick. See where the market's blowing.

Product

Markets
Theme Zones
All stocks
Compare
Hot stocks
Opportunities
News
Discussion
Watchlist
What's new

Account

Settings
Newsletter
For writers
Contact
Log in
Sign up

Markets Theme Zones All stocks Compare Hot stocks Opportunities News Discussion Watchlist What's new Settings Newsletter For writers Contact Log in Sign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Atrium Therapeutics, Inc. (RNA) Net margin — 10-Year History · Tickwind

Home/RNA/Net margin

Atrium Therapeutics, Inc. (RNA) Net margin

Atrium Therapeutics, Inc. (RNA) net profit margin by fiscal year — reported net income divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to RNA

Source: SEC XBRL filings · For reference only · Not investment advice

More RNA financial trends

RNA Revenue RNA Net income RNA Gross profit RNA Gross margin RNA Operating income RNA Operating margin RNA Operating cash flow RNA Free cash flow RNA Capital expenditures RNA Return on equity RNA Stock buybacks RNA Dividends paid RNA Total assets RNA Total liabilities RNA Shareholders’ equity RNA overview →